Building the next generation of advanced and affordable robotic solutions at the intersection of robotics and hazardous environments for firefighting, emergency response, public safety, oil & gas, and industrial.
WEAV3D is enabling lightweighting for the masses through it's patented Rebar for Plastics technology, allowing mass market manufacturing to transform their existing molding capabilities to create cost-effective, high-performance, lightweight structural composites.
At RIF Robotics, we are building PacR, a product that leverages computer vision, artificial intelligence, and robotics to streamline the inspection of surgical instruments for cleanliness and automate surgical tray assembly in hospitals and ambulatory surgery centers to eliminate surgery delays and improve patient outcomes.
As Senior Director and Partner at IndieBio, Alex is responsible for managing all of the day-to-day operations associated with the program, demo day, and the alumni network. He works closely with teams during the program on customer discovery and sales, and with investors, press, and partners to build and sustain the IndieBio ecosystem.
Join us for this candid and intimate conversation with entertainer, entrepreneur, and Tennessee native Justin Timberlake as he discusses the ups and downs of his many ventures, including celebrated Broadway hotspot the Twelve Thirty Club and the e
Hand Technologies, LLC (HAND) is a startup committed to developing and commercializing high-performance polymers and ultra-high temperature carbon/ceramic materials for the U.S. aerospace and defense market.
Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.
Moleculera Biosciences is a precision diagnostics company pioneering clinical diagnostics services for inflammatory brain and cardiovascular disorders using an integrated business model. The company enables clinicians to accurately diagnose, treat, and monitor patients suffering from chronic immune-mediated disorders, leading to remarkable recoveries.
Key highlights include:
We create human-mimicking artificial tumors for high-throughput drug screening, enabling more accurate identification of promising drugs during the preclinical stage.
Labor and Delivery technology that improves risk prediction 10x for postpartum hemorrhage, saving lives, reducing maternal complications and cutting obstetrics costs for health systems and payers.
